TERT and hepatocellular carcinoma: Similar to Oversoe et al., other studies also showed that in ctDNA from patients with HCC, TERT promoter mutations were found in 44–54.6% of all patients and were associated with large intrahepatic tumor size, elevated des-gamma carboxyprothrombin levels, and shorter survival [107,108,110].